Introduction
The ability of 17␤-estradiol (E 2 ) to increase dendritic spine density on CA1 pyramidal neurons in ovariectomized female rats is one of the most seminal and replicated findings in behavioral neuroendocrinology Woolley and McEwen, 1993; MacLusky et al., 2005; Phan et al., 2012 ), yet the molecular mechanisms regulating E 2 -induced spinogenesis in the hippocampus and elsewhere in the brain remain largely unclear. In the dorsal hippocampus (DH), E 2 significantly increases CA1 dendritic spine density within 30 min of systemic injection (MacLusky et al., 2005; Inagaki et al., 2012) . The E 2 -induced facilitation of spinogenesis peaks 2-3 d after systemic injection (Woolley and McEwen, 1993) and is associated with enhanced hippocampal synaptic plasticity (Woolley et al., 1997; Foy et al., 1999; Mukai et al., 2007) and memory formation (Inagaki et al., 2012; Phan et al., 2012) . E 2 also affects spinogenesis in other brain regions that mediate learning and memory, such as the medial prefrontal cortex (mPFC; Kesner et al., 1996; Inagaki et al., 2012; Yang et al., 2014) , where E 2 increases pyramidal spine density from 30 min to 24 h after systemic injection (Inagaki et al., 2012; Phan et al., 2012) . Given the putative role of spinogenesis in synaptic plasticity, estrogenic regulation of spines in regions, such as the DH and mPFC, is likely instrumental for E 2 to regulate memory formation (Luine and Frankfurt, 2013) .
However, the molecular mechanisms through which E 2 regulates in vivo spine density are unclear. Spinogenesis requires protein synthesis, which could occur via nuclear transcriptional or by local protein synthesis within dendrites. The rapidity with which E 2 mediates spinogenesis suggests the involvement of local protein synthesis mechanisms such as mammalian target of rapamycin (mTOR) signaling (Hoeffer and Klann, 2010) . mTOR is activated by multiple kinases, including extracellular signalregulated kinase (ERK; Ma et al., 2007; Winter et al., 2011) . Within the DH, activation of ERK and mTOR is necessary for E 2 to enhance object recognition and spatial memory consolidation in ovariectomized female mice (Fortress et al., 2013) . Specifically, DH infusion of the ERK inhibitor U0126 or mTOR inhibitor rapamycin prevents E 2 from enhancing memory and increasing p42 ERK phosphorylation (Fernandez et al., 2008; Fortress et al., 2013) . Given the importance of DH ERK and mTOR activation for E 2 -induced memory enhancement, we hypothesized that these signaling pathways would also be involved in E 2 -induced spinogenesis. Although ERK activation is necessary for E 2 to increase dendritic spines in cultured cortical and hippocampal neurons and slices (Mukai et al., 2007; Srivastava et al., 2008; Hasegawa et al., 2015; Murakami et al., 2015) , the involvement of ERK and mTOR activation in E 2 -mediated spinogenesis in vivo is unknown.
We tested whether DH infusion of E 2 regulates dendritic spine density in the DH and other brain regions, and examined the contribution of DH ERK and mTOR activation to E 2 -induced spinogenesis. DH-infused E 2 increased dendritic spine density within 30 min in the DH and within 2 h in the mPFC, suggesting that E 2 -induced DH spinogenesis may drive mPFC spinogenesis. Moreover, E 2 -induced spine changes in both brain regions required ERK and mTOR activation in the DH, providing the first evidence that specific cell-signaling pathways regulate E 2 -induced spinogenesis in vivo.
Materials and Methods
Subjects. Experiments used 8-to 12-week-old female C57BL/6 mice (Taconic Biosciences) as subjects (n ϭ 5-7/group). Mice were group-housed until surgery, after which they were singly housed. Mice were maintained on a 12 h light/dark cycle with ad libitum access to food and water. All procedures were approved by the University of Wisconsin-Milwaukee Institutional Animal Care and Use Committee in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals.
Surgery. Immediately before surgery, mice received 5 mg/kg of Rimadyl subcutaneously for pain management. They were anesthetized with isoflurane in 100% oxygen and placed in a stereotaxic apparatus for ovariectomy and cannula implantation (Boulware et al., 2013; Fortress et al., 2013) . Mice were implanted with stainless steel bilateral guide cannulae (Plastics One) aimed at the DH only [C232GC, 22 gauge; Ϫ1.7 mm AP, Ϯ1.5 mm ML, and Ϫ2.3 mm DV (injection site)] or at the DH and dorsal third ventricle [intracerebroventricular (ICV); C232GC, 22 gauge; Ϫ0.9 mm AP, Ϯ 0.0 mm ML, and Ϫ2.8 mm DV (injection site)]. Cannulae were fixed to the skull with dental cement (Darby Dental) that also closed the wound. Dummy cannulae (C232DC; Plastics One) were used to prevent clogging. Postsurgical analgesia was provided by MediGel CPF (ClearH 2 O). Mice recovered 1 week before infusion.
Drugs and Infusions. In Experiment 1, mice received bilateral DH infusions of vehicle or E 2 and were killed 30 min or 2 h later. Hydroxypropyl-␤-cyclodextrin (HBC)-encapsulated E 2 (Sigma-Aldrich) was dissolved in 0.9% sterile saline to 10 g/l and infused at 0.5 l/min for 1 min/hemisphere (Fernandez et al., 2008; Fortress et al., 2013) . The vehicle was HBC (SigmaAldrich) dissolved in saline to the same concentration of cyclodextrin present in the E 2 solution. In Experiment 2, mice received DH infusion of DMSO vehicle or a cell-signaling inhibitor, followed immediately by ICV infusion of HBC vehicle or E 2 (Fortress et al., 2013) . The MEK inhibitor 1,4-diamino-2,3-dicyano-1,4-bis(o-aminophenyl-mercapto)butadiene (U0126; Promega) was dissolved in 50% DMSO to 1.0 g/l, and the mTOR inhibitor rapamycin was dissolved in 50% DMSO to 0.025 ng/l. Bilateral DH infusions of 0.5 l DMSO vehicle, U0126, or rapamycin were immediately followed by ICV infusion (0.5 l/min for 2 min) of 10 g/l E 2 or HBC vehicle. Bilateral DH infusion of 5 g E 2 or ICV infusion of 10 g E 2 enhances object recognition and object placement memory in ovariectomized mice (Boulware et al., 2013; Fortress et al., 2013) .
Golgi impregnation and spine counting. Mice were cervically dislocated and decapitated 30 min or 2 h after infusion. Golgi impregnation was performed as described previously (Frankfurt et al., 2011) using the Rapid GolgiStain Kit (FD NeuroTechnologies). Secondary basal dendrites and tertiary apical dendrites were counted blindly from pyramidal neurons in dorsal hippocampal CA1 and layer II/III of the prelimbic mPFC. Spines were also counted on granule cells and neurons from the ventromedial hypothalamic nucleus (VMN). Dendrites from six cells/ region/brain were included in the analysis, and five to seven brains were quantified/group. Neurons were chosen for analyses as described previously . Spines were counted on a Nikon Eclipse E400 microscope under oil (100ϫ) using a hand counter, and dendritic length was measured using Spot Advanced v5.0 Windows (Diagnostic Instruments). Spine density was calculated by dividing spine number by dendrite length. Data were expressed as number of spines/10 m dendrite.
Data Analysis. For Experiment 1 (E 2 only), two-way ANOVAs (treatment ϫ time) were conducted separately for apical and basal spine density in each brain region. For Experiment 2 (E 2 plus inhibitors), one-way ANOVAs were conducted to measure treatment effects on spines 2 h postinfusion. Post hoc tests (Tukey, Fisher's least significance difference) assessed between-group differences.
Results

DH E 2 infusion increased CA1 spine density 30 min and 2 h later
Main effects of treatment and time were significant for basal (Fig. 1A; F (1, 22) ϭ 63.37, p Ͻ 0.0001 and F (1,22) ϭ 8.93, p ϭ 0.007, respectively) and apical ( Fig. 1B; F (1,22) ϭ 46.46, p Ͻ 0.0001 and F (1, 22) ϭ 7.25, p ϭ 0.013, respectively) CA1 dendrites. Relative to vehicle, E 2 increased CA1 basal ( p Ͻ 0.0001) and apical ( p Ͻ 0.01) spine density within 30 min. This effect remained significant for both basal and apical dendrites 2 h after infusion ( p values Ͻ0.0001). These data demonstrate that DH E 2 infusion induces a rapid increase in apical and basal CA1 spine density that lasts at least 2 h.
DH E 2 infusion did not affect spine density in the dentate gyrus
To demonstrate specificity of E 2 effects within the DH, we examined dendritic spine density in the dentate gyrus, which exhibits increased neurogenesis in response to E 2 (Tanapat et al., 2005; Galea et al., 2006; Barha et al., 2009 ). The main effect of time was significant (F (1, 20) ϭ 18.13, p ϭ 0.0004), such that fewer spines were observed 2 h after infusion than 30 min after infusion (Fig.  1C) . However, E 2 had no effect on spines at either time point ( p Ͼ 0.05).
DH infusion of E 2 increased basal spine density in mPFC 2 h after infusion
Main effects of treatment (F (1,20) ϭ 18.47, p ϭ 0.0004) and time (F (1,20) ϭ 17.3, p ϭ 0.0005) were significant for basal mPFC dendrites ( Fig. 2A) , as was the main effect of treatment (F (1,20) ϭ 5.0, p ϭ 0.037) for apical mPFC dendrites (Fig. 2B) . DH E 2 infusion did not significantly alter apical or basal spine density in the mPFC 30 min later, although a trend for an increase was evident for both types of spines. Indeed, E 2 significantly increased basal ( p Ͻ 0.01), but not apical, spine density 2 h later (Fig. 2 A, B) . Thus, DH E 2 infusion increased basal spine density in the mPFC within 2 h, suggesting that estrogenic regulation of DH spinogenesis may alter mPFC spine morphology.
E 2 did not influence spine density in the VMN
The effects of DH E 2 infusion on mPFC spines might result from exogenous E 2 diffusing outside of the DH. Because systemic E 2 treatment increases spinogenesis in the VMN, we examined spine density in this region (Frankfurt et al., 1990) . The main effect of time was significant (F (1, 22) ϭ 24.1, p Ͻ 0.0001), such that fewer spines were observed 2 h after infusion than 30 min after infusion (Fig. 2C) . However, no effect of E 2 was observed at either time point ( p values Ͼ0.05). These data support a more specific effect of DH E 2 infusion on mPFC spine density.
E 2 -induced spine changes in the DH and mPFC depend on DH ERK and mTOR signaling
To determine whether E 2 -induced spine changes in CA1 and mPFC depend upon rapid activation of ERK and mTOR signaling, mice received bilateral DH infusions of DMSO vehicle, the ERK inhibitor U0126, or the mTOR inhibitor rapamycin, followed immediately by ICV infusion of HBC vehicle or E 2 . Brains were collected 2 h later. Importantly, the inhibitor doses used do not impair object recognition memory or p42-ERK phosphorylation on their own, yet block the memory-enhancing effects of E 2 (Fortress et al., 2013) . In CA1, the main effect of group was significant for basal (F (3,22) ϭ 10.59, p ϭ 0.0002; Fig. 3A ) and apical (F (3,22) ϭ 6.11, p ϭ 0.004; Fig. 3B ) spines. Mice receiving E 2 ϩvehicle exhibited a significant increase in basal ( p Ͻ 0.01) and apical ( p Ͻ 0.05) CA1 spine density 2 h after infusion relative to vehicle controls. This increase was blocked for basal and apical spines (Fig. 3 A, B ) in mice receiving DH infusions of U0126 ( p Ͻ 0.001 relative to E 2 ϩvehicle) or rapamycin ( p Ͻ 0.01 relative to E 2 ϩvehicle), suggesting that ERK and mTOR activation are necessary for E 2 to increase CA1 spine density.
Interestingly, DH ERK and mTOR activation also regulated mPFC spine formation. mPFC spine density was significantly altered 2 h after infusion for basal (F (3,19) ϭ 11.49, p ϭ 0.0002) and apical (F (3,19) ϭ 7.04, p ϭ 0.002) spines. As in CA1, mice infused with E 2 ϩvehicle exhibited significantly greater basal ( p Ͻ 0.01) and apical ( p Ͻ 0.01) spine density than vehicle controls. Again, these increases were blocked by U0126 ( p Ͻ 0.01 relative to E 2 ϩvehicle) or rapamycin ( p Ͻ 0.05 relative to E 2 ϩvehicle), indicating that activation of ERK or mTOR in the DH is necessary for DH-infused E 2 to increase mPFC spine density. 
Discussion
Our findings provide several novel insights into the mechanisms through which E 2 induces dendritic spine density in CA1 and mPFC. DH infusion of E 2 significantly increased basal and apical spine density on CA1 pyramidal dendrites within 30 min, an effect that persisted for 2 h. DH or ICV infusion of E 2 also significantly increased basal spine density on mPFC pyramidal neurons within 2 h. Although systemic E 2 injection increases spinogenesis in these brain regions (Inagaki et al., 2012; Luine and Frankfurt, 2012) , this is the first demonstration that DH or ICV E 2 infusion increases CA1 and mPFC spine density, and that DH E 2 infusion drives mPFC spine changes. Importantly, DH E 2 infusion did not alter spines in the dentate or VMN, suggesting an effect specific to CA1 and mPFC. DH infusion of U0126 or rapamycin blocked the spine increase observed in CA1 and mPFC 2 h after ICV E 2 infusion, indicating that E 2 -mediated spinogenesis requires ERK and mTOR activation. Together, these data suggest the involvement of local protein translation in E 2 -mediated spine alterations, and indicate that E 2 -induced DH cell signaling regulates mPFC spine density.
These data provide novel evidence that E 2 -induced hippocampal alterations impact spine density in the mPFC. The CA1 findings were consistent with classic studies demonstrating that naturally elevated or systemically injected E 2 increases CA1 dendritic spine density . The mPFC findings were more surprising. Although a dose of systemic E 2 that enhances hippocampal memory increases CA1 and mPFC spine density in ovariectomized rats (Inagaki et al., 2012) and mice (Phan et al., 2012) , the dependence of spine changes in one region on E 2 -induced alterations in the other has never been investigated. The present results highlight a previously unexplored interaction between the DH and mPFC that may have important implications for understanding how E 2 regulates memory. Presently, the mechanisms through which DH E 2 infusion affects mPFC spine density are unclear. Sparse projections from dorsal CA1 and subiculum to the mPFC exist, as do indirect projections through the nucleus reuniens of the thalamus and ventral hippocampus (Jay et al., 1992; Hoover and Vertes, 2007) . The functional relevance of these projections is supported by evidence that collaboration between these brain regions is important for episodic-like memory tasks (Warburton and Brown, 2015) and delayed spatial working memory (Churchwell and Kesner, 2011) . Notably, DH E 2 infusion affected basal, but not apical, spines in mPFC, which may reflect differences between presynaptic excitatory input to apical and basal domains. For example, input to basal spines in mPFC layer II/III reportedly originates from local circuitry (Spruston, 2008) . Therefore, our data suggest that DH E 2 infusion may influence local prefrontal synaptic activity, but additional experiments are necessary to substantiate this interaction. Interestingly, ICV E 2 infusion increased both basal and apical spines, which could suggest that the more anterior ICV infusion affects a subpopulation of DH pyramidal neurons that project to both apical and basal dendrites. Nevertheless, blocking ERK and mTOR signaling in the DH prevented ICV-infused E 2 from increasing spines in the mPFC, pinpointing the DH as a key regulator of ICV E 2 -mediated spinogenesis.
Our data suggest that ERK and mTOR activation is necessary for E 2 to increase CA1 and mPFC spine density. ERK activation is essential for synaptic plasticity and hippocampal-dependent memory (English and Sweatt, 1997; Atkins et al., 1998; Selcher et al., 1999) . Moreover, E 2 rapidly increases DH ERK phosphorylation in vitro (Boulware et al., 2005; Zhao and Brinton, 2007) and in vivo (Fernandez et al., 2008) , and ERK activation is necessary for E 2 to enhance hippocampal-dependent object recognition and spatial memory in female mice (Fernandez et al., 2008 ; Boul- ware et Fortress et al., 2013) . The current work extends these findings by demonstrating that E 2 -induced ERK activation is also necessary for CA1 and mPFC spinogenesis in vivo. These results are consistent with in vitro data showing that ERK inhibition blocks E 2 -induced spinogenesis in the CA1 of male hippocampal slices (Mukai et al., 2007; Hasegawa et al., 2015) and in cortical neuron cultures (Srivastava et al., 2008) .
ERK phosphorylation triggers downstream mTOR-mediated protein synthesis (Hoeffer and Klann, 2010) , which is also essential for hippocampal synaptic plasticity (Tang et al., 2002) and hippocampal-dependent memory (Bekinschtein et al., 2007; Gafford et al., 2011) . Furthermore, ERK-induced activation of mTOR signaling is required for E 2 to enhance object recognition memory in female mice (Fortress et al., 2013) . Here, rapamycin blocked the The increased CA1 and mPFC apical and basal spine density induced by ICV E 2 was blocked by ERK or mTOR inhibition. Two hours after ICV E 2 infusion, basal and apical spine density was significantly increased in the mPFC (A, B) and CA1 (C, D) relative to vehicle. These effects were blocked by DH infusion of U0126 or rapamycin. Bars represent the mean Ϯ SEM. *p Ͻ 0.05 relative to all other groups. E, Photomicrograph of Golgi-impregnated secondary basal dendrites of CA1 pyramidal cells (A, vehicle; B, E 2 ϩvehicle; C, E 2 ϩU0126). Arrows denote spines. Under oil 63ϫ.
increased CA1 and mPFC spine density 2 h after E 2 infusion, suggesting that E 2 -mediated spinogenesis depended on DH mTOR activation. Although E 2 increases mTOR phosphorylation in hippocampal slices (Briz and Baudry, 2014) , these findings provide the first in vivo demonstration that mTOR activation is necessary for E 2 to increase spine density in either brain region. Interestingly, E 2 -induced spinogenesis in the mPFC required mTOR activation in the DH, further supporting that DH cell signaling regulates mPFC spine density. Together with the aforementioned behavioral and in vitro data, these results suggest that estrogenic activation of mTORmediated protein synthesis may be essential for the local translation of transcripts that support the formation or maintenance of new spines. Because other signaling mechanisms regulate E 2 -mediated spinogenesis in cultured hippocampal or cortical neurons, including PI3K, PKA, PKC, CaMKII, and the RhoA Ͼ ROCK Ͼ LIMK Ͼ cofilin Ͼ actin pathway (Srivastava et al., 2008; Hasegawa et al., 2015) , the role of these mechanisms in mediating E 2 -induced spinogenesis in vivo should be tested in future studies.
In conclusion, the present findings demonstrate that DH E 2 infusion rapidly increases CA1 and mPFC dendritic spine density in an ERK-and mTOR-dependent fashion. These data shed new light on the molecular mechanisms underlying E 2 -induced spinogenesis in vivo, and suggest that the DH and mPFC may interact to mediate the memory-enhancing effects of E 2 . Because systemic E 2 treatments that enhance memory also increase spine density in CA1 and mPFC (Velázquez-Zamora et al., 2012; Luine and Frankfurt, 2013) , the current findings have important implications for understanding how estrogenic regulation of neural circuitry influences memory formation.
